The irbesartan in patients with type 2 diabetes and microalbuminuria (IRMA 2)

Trial Profile

The irbesartan in patients with type 2 diabetes and microalbuminuria (IRMA 2)

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Mar 2011

At a glance

  • Drugs Irbesartan (Primary)
  • Indications Diabetic nephropathies; Hypertension; Hypertension in diabetes; Proteinuria
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms IRMA-2
  • Most Recent Events

    • 31 Mar 2011 Results from a sub-study investigating the effects of treatment on nucleic acid oxidation published in the Diabetes Care.
    • 24 Sep 2010 Results from a sub-study investigating the effects of treatment on renal function presented at the 46th Annual Meeting of the European Association for the Study of Diabetes
    • 22 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top